Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Netherlands Compounding Pharmacies Market — Insights 

A pharmacy that is operated by a licensed pharmacist, licensed physician or a person under the guidance of a licensed pharmacist is called compounding pharmacy.

The Netherlands compounding pharmacies market is estimated to account for US$ 520.5 Mn in terms of value by the end of 2027.

Netherlands Compounding Pharmacies Market: Drivers

Increasing prevalence of chronic diseases is expected to boost growth of the Netherlands compounding pharmacies market over the forecast period. For instance, according to Globocan 2018, 119,923 cases of cancer were registered in the Netherlands. 

Moreover, decreasing supply of essential drugs is also expected to propel growth of the market. For instance, according to Royal Dutch Society for the Promotion of Pharmacy (KNMP), 769 medicines were unavailable at some stage during 2018, including 128 treatments that were taken out of circulation altogether.

Oral medication held dominant position in the Netherlands compounding pharmacies market in 2018, accounting for 62.9% share in terms of value, followed by topical medication.

Netherlands Compounding Pharmacies  | Coherent Market Insights

Netherlands Compounding Pharmacies Market: Restraints

However, a major factor hindering growth of the Netherlands compounding pharmacies market is adoption of unsafe compounding practices such as compounding contamination and non-adherence to GMP regulations.

Moreover, certain compounded drugs in the Netherlands have been associated with adverse drug reactions as they constitute drugs that are banned under pharmacovigilance measures. Adverse drug reactions prove detrimental to patient’s and related party’s confidence in compounded drugs. For instance, clioquinol—a drug used for controlling amoebiasis and infections with dientamoeba fragilis—is no longer registered through the Medicines Evaluation Board for systemic use in the Netherlands and is only available as a compounded drug. In 2015, according to Netherlands Pharmacovigilance Center, use of clioquinol in compounded form led to 33 reports concerning adverse drug reactions.

Netherlands Compounding Pharmacies Market: Opportunities

Increasing GMP compliance is expected to offer lucrative growth opportunities for players in the Netherlands compounding pharmacies market. Currently, inspection for adherence to GMP guidelines is only available for industrial manufacturing of drugs in the Netherlands. However, community compounding pharmacies need to adhere to best practice guidelines, as hospitals in the country are expected to outsource more drug compounding to the community compounding pharmacies.

Key players in the market can also focus on R&D of products related to geriatric and long-term care and innovative Hormone replacement therapy (HRT) applications to expand their product portfolio.

Netherlands Compounding Pharmacies  | Coherent Market Insights

Medication of adults segment in the Netherlands compounding pharmacies market was valued at US$ 136.6 Mn in 2018 and is expected to reach US$ 287.8 Mn by 2027 at a CAGR of 8.6% during the forecast period.

Market Trends/Key Takeaways

The market is witnessing increasing preference for HRT drugs for indications such as menopausal symptoms, men’s health (andropause), and weight loss. However, untested ingredients, possibility of microbiological contaminations, errors in defining dosages of hormones and declining reimbursements from government are some of the factors that may hamper demand for HRT drugs in the Netherlands.

In the Netherlands, products are primarily purchased from specialized compounding companies and products from major market players are in high demand compared to those of community compounding pharmacies. Moreover, a majority of compounded drugs are outsourced to hospitals.

Netherlands Compounding Pharmacies Market: Competitive Landscape

Major players operating in the Netherlands compounding pharmacies market include, GMP Apotheek Mierlo Hout, Apotheek A15, Vemedia, and Fagron.

Netherlands Compounding Pharmacies Market: Key Developments

Key players in the market are focused on geographical expansion through M&A activities. For instance, in May 2019, Fagron entered into an agreement to acquire Central de Drogas, S.A. de C.V., a leading supplier of raw materials to compounding pharmacies and the pharmaceutical industry in Mexico.

Key players in the market are also focused on product development to expand their product portfolio. For instance, in November 2018, AMC, a hospital in Amsterdam focused on producing compounding drugs, received permission from the Dutch Health and Youth Care Inspectorate to produce an equivalent of chenodeoxycholic acid (CDCA) if the used resources meet the quality standards.

Compounding pharmacies constitutes of compounding of pharmaceutical products tailor made in accordance with the needs of the patient. Compounding pharmacies is a type of personalized medicine and caters to specific needs of the patients. Increasing government initiatives to reduce drug cost of expected to assist the market growth. For instance, on February 2019, Dutch government passed new a provision to the Dutch Patent Act 1995 which allows pharmacists to prepare patented medicines in small scale for patients. The new amendment is aims at providing cheaper alternative to branded drugs.

Key features of the study:

  • This report provides in-depth analysis of the Compounding Pharmacies market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Netherlands Compounding Pharmacies market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, GMP Apotheek Mierlo Hout, Apotheek A15, Vemedia, and Fagron
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Netherlands Compounding Pharmacies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Netherlands Compounding Pharmacies market

Detailed Segmentation:

  • Netherlands Compounding Pharmacies Market, By Product Type:
    • Mouthwashes
    • Oral Medication
      • Capsule
      • Lollipops
      • Lozenges
      • Suspensions
      • Tablets
    • Suppositories
    • Topical Medication
      • Cream
      • Gels
      • Lotions
      • Ointments
  • Netherlands Compounding Pharmacies Market, By Application:
    • Medication for Adults
    • Medication for Children
    • Medication for Geriatric
    • Medication for Veterinary
  • Netherlands Compounding Pharmacies Market, By Therapeutic Area:
    • Hormone Replacement Therapy
    • Pain Management
  • Netherlands Compounding Pharmacies Market, By Facilities:
    • Community Pharmacies
    • Hospitals
  • Company Profiles
    • GMP Apotheek Mierlo Hout *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Apotheek A15
    • Vemedia
    • Fagron

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By Therapeutic Area
      • Market Snippet, By Facility
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Advancements
    • Key Highlights
    • Regulatory Scenario
    • Technological Advancements
    • PEST Analysis
    • Epidemiology
  4. Netherlands Compounding Pharmacies Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Mouthwashes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Orals Medications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Capsule
        • Lollipops
        • Lozenges
        • Suspensions
        • Tablets
    • Suppositories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Topical Medications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Cream
        • Gels
        • Lotions
        • Ointments
  5. Netherlands Compounding Pharmacies Market, By Application, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Medication for Adults
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Medication for Children
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Medication for Geriatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Medication for Veterinary
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Netherlands Compounding Pharmacies Market, By Therapeutic Area, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hormone Replacement Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Pain Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Netherlands Compounding Pharmacies Market, By Facilities, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Community Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Competitive Landscape
    • Company Profiles
      • GMP Apotheek Mierlo Hout
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Apotheek A15
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vemedia
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fagron
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 20 market data tables and 22 figures on “Netherlands Compounding Pharmacies Market - forecast to 2027”.

Frequently Asked Questions

The Netherlands compounding pharmacies market is estimated to account for US$ 520.5 Mn, in terms of value by the end of 2027.
Major players operating in the Netherlands compounding pharmacies market include GMP Apotheek Mierlo Hout, Apotheek A15, Vemedia, and Fagron.
Adoption of unsafe compounding practices such as compounding contamination and non-adherence to GMP regulations are some of the factors that are expected to hinder growth of the market over the forecast period.
The increasing prevalence of chronic diseases, coupled with low supply of essential drugs are the major factors that are expected to propel growth of the market over the forecast period.
Rising preference for HRT drugs indicated for menopausal symptoms, men’s health (andropause), and weight loss is one of the major trends that is observed in the market.
Among product type, oral medication segment held a dominant position in the Netherlands compounding pharmacies market in 2018, accounting for 62.9% share in terms of value, followed by topical medication segment.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner